SINTX Technologies Inc logo

SINTX Technologies Inc(SINT)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL
1-STAR RATING
PASS
LAST CLOSE
$1.34
11/13/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for SINT

11/13/2026: SINT (1-star) is currently NOT-A-BUY. Pass it for now.

SINTX Technologies is a specialized material science company that focuses on the development and production of silicon nitride, a ceramic known for its durability and antimicrobial properties. The company is currently transitioning from a medical-only focus to a broader model that includes industrial and defense applications, as well as contract manufacturing services. While its unique material platform provides a distinct niche, SINTX faces significant challenges regarding commercial scale, historical financial losses, and heavy reliance on external financing. It is best suited for investors comfortable with high-risk, speculative material science plays. Key developments to monitor include commercial contract wins and progress in scaling its contract manufacturing services.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorWeak fitThe company is in an early, high-risk stage of commercializing its technology.
Momentum investorWeak fitThe stock lacks the consistent positive price trends favored by momentum strategies.
Value investorWeak fitThe company's lack of consistent profitability makes traditional value metrics difficult to apply.
Dividend investorWeak fitSINTX pays no dividends and is unlikely to do so in the near future.
Low-risk investorWeak fitHigh volatility and operational uncertainty make this a poor fit for risk-averse investors.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityHighSmall-cap stocks in the medical technology space often experience large, rapid price swings.
Valuation riskHighInvestors are pricing in future potential rather than current, stable earnings.
Competition riskHighThe company competes with massive, well-capitalized medical device firms.
Business qualityMediumThe underlying proprietary material technology is strong, but the business model is still evolving.
Dividend incomeLow / noneThere is no income generation for investors.
Execution riskHighSuccessfully scaling manufacturing and gaining commercial adoption remains the primary hurdle.

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 10.17M USD
Price to earnings Ratio -
1Y Target Price 9.25
Price to earnings Ratio -
1Y Target Price 9.25
Volume (30-day avg) 39.3K shares
Beta 0.57
52 Weeks Range 1.33 - 4.46
Updated Date 11/13/2026
52 Weeks Range 1.33 - 4.46
Updated Date 11/13/2026
Dividends yield (FY) -
Basic EPS (TTM) -1.37

Sector & Industry Intelligence

Sector

Healthcare

Bullish
Sentiment
Strong Bullish
Momentum
Momentum Steady
BUY participation
62.6%
Active BUY / eligible
72 / 115
30-Day BUY Count Change
+35
Market state
Strong Bullish

The number of qualifying BUY stocks has remained relatively stable.

Industry

Medical Devices

BUY participation
62.5%
Active BUY / eligible
5 / 8
30-Day BUY Count Change
+3

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Steep Decline
PRICE PATH

Steep Decline

The stock price has dropped sharply with strong downward pressure.

Choppy
PRICE STABILITY

Choppy

The stock has experienced frequent reversals and pronounced short-term price swings.

Analysis of Past Performance

Type Stock
Historic Profit -29.45%
Avg. Invested days 10
Today’s Advisory PASS
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 2.0
Stock Returns Performance Upturn Returns Performance icon 1.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/13/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
SINT receives a 2-star rating, supported by solid analyst coverage. The rating is constrained by weak unit economics, soft company fundamentals, and weak price momentum.

Company Fundamentals

★★★★★
SINT has soft overall fundamentals (2 stars), with soft financial health, soft growth momentum, and solid ownership. In FY2025 versus FY2024, growth and ownership metrics are mixed: negative earnings growth (-55.0%), weak cash generation (FCF margin -860.5%), negative revenue growth (-18.3%).

Financial Health Rating

★★★★★
SINT's financial health is soft, with the relatively strongest area being moderate liquidity, including working-capital and asset support (WC/assets 20.2%). Operating efficiency is weak (1 stars), which helps explain the 2-star overall score.

Growth Momentum Score

★★★★★
Free-cash-flow growth is SINT's strongest growth driver at +6.1% FY2025 versus FY2024 (moderate, 3 stars). By comparison, while revenue growth (-18.3%, negative) and earnings growth (-55.0%, negative) hold the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 12.6% and approximately 82.2% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership of 26.92% supports management-shareholder alignment.

Top 5 Institutional Investors

Bleichroeder LP 7.85%
Stonepine Capital Management Llc 3.14%
Veracity Capital LLC 1.15%
Citadel Advisors Llc 0.48%
Geode Capital Management, LLC 0.45%

Unit Economics (Per $1K Revenue)

★★★★★
SINT generates approximately $-197 of gross profit, $-10,531 of operating income, and $-8,605 of free cash flow for every $1,000 of revenue. Based on FY2025 results. Operating losses and cash burn explain the 1-star rating, with weak cash conversion and weak capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: -64.83% (Tax Credit)

Quantitative Style Profile

★★★★★
SINT has a liquid, relatively low-volatility profile. Weak momentum is the primary drawback.

Style Classification

Quality Focused

Value-OrientedLow VolatilitySmall / Mid Cap RiskHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Medical CeramicsSale of silicon nitride implants and associated R&D activities.The company tries to get surgeons to choose their implants over standard titanium or plastic options.
Industrial/Technical CeramicsSale of silicon nitride powder and contract manufacturing services.The company sells its high-strength material to other manufacturers for use in extreme environments.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Valuation

Trailing PE -
Forward PE -
Enterprise Value 12.56M
Price to Sales(TTM) 3.07
Enterprise Value 12.56M
Price to Sales(TTM) 3.07
Enterprise Value to Revenue 4.15
Enterprise Value to EBITDA -0.56
Shares Outstanding 7.56M
Shares Floating 6.21M
Shares Outstanding 7.56M
Shares Floating 6.21M
Percent Insiders 26.92
Percent Institutions 12.61

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.